why choose us

First received: November 15, 2022

Clinical Trial: Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

Study Status: Completed

Recruit Status: RECRUITING

Condition: Urgency Urinary Incontinence

Study Type: INTERVENTIONAL


Official Title: Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

Brief Summary: The goal of this clinical trial is to compare treatment outcomes between an oral medication (beta agonist) versus onabotulinumtoxinA injections in women with urgency urinary incontinence (UUI).Participants will be randomly selected to receive one of the two treatments.The primary outcome measure will be at 3 months, and women will be followed for a total of 12 months.Based on patient expert input, there are 2 primary outcomes: Treatment satisfaction and urinary symptom severity.

Read more